Latest News

20 July 2021

Digital Technology Driving Tangible Advancements in Parkinson’s Disease Research and Clinical Care

Amsterdam, NL – Well over six million people globally have been diagnosed with Parkinson’s disease (PD), which has an enormous impact on the lives of patients, their families, and caregivers and is incurring mounting costs for society.

3 February 2021

COVID-19 Vaccination for Patients with Parkinson’s Disease Recommended

Patients with Parkinson’s disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine’s efficacy and safety in the specific context of PD and its symptomatic treatment. In a commentary just published in JPD, a set of experts addresses these concerns from an evidence-based perspective. Their conclusion is that COVID-19 vaccination with approved vaccines should be recommended to persons with PD, unless there is a specific contraindication.

25 September 2020

JPD and MJFF Accelerating the Publication of Parkinson's Disease Publication Data

Call for Submissions: To address the bias toward the publication of novel positive results, The Michael J. Fox Foundation for Parkinson’s Research and JPD invite researchers to “open their notebooks” and submit unpublished results from experiments that attempted to replicate previously published findings from other laboratories.

22 September 2020

Neurological Consequences of COVID-19: The “Silent Wave”

Is the world prepared a wave of neurological consequences that may be on its way as a result of COVID-19? This question is at the forefront of research underway at the Florey Institute of Neuroscience and Mental Health. A team of neuroscientists and clinicians are examining the potential link between COVID-19 and increased risk of Parkinson’s disease, and measures to get ahead of the curve.

Pages

Subscribe to Latest News